Clene Inc. (CLNN)
CLNN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.39
-7.88% on the day
Market cap
$48.2M
Nano cap
Revenue · 2025
$200K
-41.5% on 2024
Net income · 2025
-$26.2M
-13086.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CLNN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001822791 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $200K |
| Net income | -$26.2M |
| Operating income | -$23.1M |
| Net margin | -13086.5% |
| Operating margin | -11541.5% |
| Revenue growth | -41.5% |
| Cash | $5.2M |
| Total assets | $18.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 240.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B5 | 424B5 | 2026-09-16 |
| Latest annual report FORM 10-K | 10-K | 2026-03-17 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-14 |
| Latest current report FORM 8-K | 8-K | 2026-09-16 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-04-10 |
Source: SEC EDGAR submissions feed, 700 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HOWL | Werewolf Therapeutics Inc. | $0.9911 | +0.95% | $48.2M |
| ELTX | Elicio Therapeutics Inc. | $1.77 | -5.85% | $48.0M |
| ACET | Adicet Bio Inc. | $5.11 | -7.59% | $47.8M |
| SER | Serina Therapeutics Inc. | $1.82 | -6.19% | $46.2M |
| IBIO | iBio Inc. | $0.7818 | -13.44% | $50.3M |
| CELU | Celularity Inc. | $1.42 | -3.40% | $46.1M |
| MREO | Mereo BioPharma Group plc | $0.3200 | +1.52% | $51.1M |
| ANVS | Annovis Bio Inc. | $1.06 | -7.83% | $45.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier